NCT01514448 2017-07-19Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or PazopanibNovartisPhase 4 Completed29 enrolled 9 charts
NCT02056587 2014-02-06Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab TreatmentKidney Cancer Research BureauPhase 4 Completed37 enrolled